References
- Lyytinen I, Lempinen M, Nordin A, Mäkisalo H, Stenman U, Isoniemi H. Prognostic significance of tumor-associated trypsin inhibitor (TATI) and human chorionic gonadotropin-β (hCGβ) in patients with hepatocellular carcinoma. Scand J Gastroenterol 2013;48:1066–73.
- Birgisson H, Jirström K, Stenman U. Serum concentrations of human chorionic gonadotropin beta and its association with survival in patients with colorectal cancer. Cancer Biomark 2012;11:173–81.
- Pasanen P, Eskelinen M, Kulju A, Penttilä I, Janatuinen E, Alhava E. Tumour-associated trypsin inhibitor (TATI) in patients with colorectal cancer: a comparison with CEA, CA 50 and CA 242. Scand J Clin Lab Invest 1995;55:119–24.
- Paju A, Vartiainen J, Haglund C, et al. Expression of trypsinogen-1, trypsinogen-2, and tumor-associated trypsin inhibitor in ovarian cancer prognostic study on tissue and serum. Clin Cancer Res 2004;10:4761–8.
- Wiksten J, Lundin J, Nordling S, Kokkola A, Stenman U, Haglund C. High tissue expression of tumour-associated trypsin inhibitor (TATI) associates with a more favourable prognosis in gastric cancer. Histopathology 2005;46:380–8.
- Piantino P, Aroasio E. Tumor-associated trypsin inhibitor, TATI, in gastrointestinal cancer and related benign diseases. Scand J Clin Lab Invest 1991;51:67–9.
- Koivunen E, Saksela O, Itkonen O, Osman S, Huhtala M, Stenman U. Human colon carcinoma, fibrosarcoma and leukemia cell lines produce tumor-associated trypsinogen. Int J Cancer 1991;47:592–6.
- Solakidi S, Tiniakos D, Petraki K, et al. Co-expression of trypsin and tumour-associated trypsin inhibitor (TATI) in colorectal adenocarcinomas. Histol Histopathol 2003;18:1181–8.
- Koskensalo S, Hagström J, Louhimo J, Stenman U, Haglund C. Tumour-associated trypsin inhibitor TATI is a prognostic marker in colorectal cancer. Oncology 2012;82:234–41.
- Gaber A, Johansson M, Stenman U, et al. High expression of tumour-associated trypsin inhibitor correlates with liver metastasis and poor prognosis in colorectal cancer. Br J Cancer 2009;100:1540–8.
- Brown A, Shaheen NJ. Screening for upper gastrointestinal tract malignancies. Semin Oncol 2004;31:487–97.
- Cui Y, Bi M, Su T, Liu H, Lu S. Molecular cloning and characterization of a novel esophageal cancer related gene. Int J Oncol 2010;37:1521.
- Gion M, Mione R, Tremolada C, et al. Tumor-associated trypsin inhibitor (TATI) in primary esophageal carcinoma. Scand J Clin Lab Invest 1991;51:37–41.
- Alexander G, Helgi B, Xiao-Feng S. Prognostic role of tumour associated trypsin inhibitor in colorectal cancer patients. Lund University; Faculty of Medicine Doctoral Dissertation Series 2012 2012.